SNIPR Biome
Copenhagen
About SNIPR Biome
SNIPR Biome is a operator of a discovery stage biotech company intended to revolutionize the treatment of microbial diseases. The company uses CRISPR technology that can subvert elements of the endogenous bacterial CRISPR machinery to eliminate hazardous bacteria in vivo, providing the health professionals with medicines that selectively target and kill bacteria with specific DNA sequences.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $103.4M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2025)
- Website: sniprbiome.com
- Phone: [email protected]
Industries & Categories
Biometrics, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/snipr-biome-12704 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.